Bank Of Nova Scotia Sarepta Therapeutics, Inc. Transaction History
Bank Of Nova Scotia
- $47.4 Billion
- Q3 2024
A detailed history of Bank Of Nova Scotia transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Bank Of Nova Scotia holds 252,768 shares of SRPT stock, worth $31.5 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
252,768
Previous 252,825
0.02%
Holding current value
$31.5 Million
Previous $39.9 Million
20.97%
% of portfolio
0.07%
Previous 0.07%
Shares
10 transactions
Others Institutions Holding SRPT
# of Institutions
529Shares Held
84.1MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.29 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.12 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$781 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$544 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$533 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $10.9B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...